Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38199
CAS Number:
135575-42-7
Pneumocandin B0
Purity:
≥ 96% (HPLC)
Documents
$213.62 /10MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Pneumocandin B0 is a potent lipopeptide compound recognized for its significant antifungal properties, particularly against Candida species. This compound is a derivative of echinocandin, which is widely utilized in the pharmaceutical industry for the treatment of invasive fungal infections. Its unique structure allows it to inhibit the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, making it a valuable agent in antifungal therapy. Researchers and industry professionals can leverage Pneumocandin B0 in the development of new antifungal medications, especially in cases where traditional treatments have failed.

In addition to its therapeutic applications, Pneumocandin B0 has shown promise in agricultural settings, where it can be used to protect crops from fungal pathogens. Its efficacy in both medical and agricultural domains highlights its versatility and potential for broader applications. With its favorable safety profile and targeted action, Pneumocandin B0 stands out as a crucial compound for researchers aiming to innovate in antifungal treatments and crop protection solutions.

CAS Number
135575-42-7
Purity
≥ 96% (HPLC)
Molecular Formula
C50H80N8O17
Molecular Weight
1065.23
MDL Number
MFCD28168025
PubChem ID
15115604
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
General Information
CAS Number
135575-42-7
Purity
≥ 96% (HPLC)
Molecular Formula
C50H80N8O17
Molecular Weight
1065.23
MDL Number
MFCD28168025
PubChem ID
15115604
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Pneumocandin B0 is widely utilized in research focused on:

  • Antifungal Development: This compound serves as a precursor in the synthesis of echinocandin antifungal agents, which are crucial in treating invasive fungal infections, particularly in immunocompromised patients.
  • Pharmaceutical Research: It plays a significant role in drug formulation studies, helping researchers understand the pharmacokinetics and efficacy of new antifungal therapies.
  • Biotechnology: Pneumocandin B0 is used in the production of biopharmaceuticals, leveraging its properties to enhance the stability and effectiveness of biologic drugs.
  • Microbial Studies: Researchers utilize this compound to study the mechanisms of fungal resistance, aiding in the development of more effective antifungal strategies.
  • Clinical Applications: Its derivatives are explored in clinical settings for their potential to treat various fungal infections, providing alternatives to traditional antifungal medications.

Citations